REPLIGEN CORP (RGEN)
Biological Products, (No Diagnostic Substances) · Healthcare · $7.4B
Intrinsic Value (Consensus)
$23.43
Current Price
$131.69
Margin of Safety
-82.2%
82.2% Above Intrinsic Value
Value: $23
Price: $132
Valuation Model Estimates
Current Price: $131.69
DCF (Discounted Cash Flow)
$26.20
Graham Number
$26.88
Earnings Power Value
$8.35
Relative Value (P/E)
$17.20
Dividend Discount Model
Not applicable
—
Consensus Value
$23.43
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
59
Profitability
12/25
Strength
24/25
Valuation
7/25
Growth
16/25
Financial Health Signals
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $0.86
- EPS (Forward)
- $0.90
- Book Value
- $37.34
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 2.3%
- Debt/Equity
- 26%
- Revenue Growth
- 286.1%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance